A subgroup of CASR gain-of-function variants leads to renal loss of sodium, chloride and magnesium resulting in hyperreninemia, hyperaldosteronism with normal blood pressure, hypokalemia and metabolic alkalosis, in addition to hypocalcemia and relative hypercalciuria. Here, CASR is linked to Hypercalciuria.